Marshall Wace
IMVT icon

Marshall Wace’s Immunovant IMVT Stock Holding History

Marshall Wace’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.49M Sell
142,488
-22,812
-14% -$695K ﹤0.01% 1321
2026
Q1 		$4.11M Buy
+165,300
New +$4.28M ﹤0.01% 1396
2025
Q4 		– Sell
-419,680
Closed -$6.77M – 3186
2025
Q3 		$6.77M Buy
+419,680
New +$6.79M 0.01% 1073
2025
Q2 		– Sell
-138,477
Closed -$2.37M – 2915
2025
Q1 		$2.37M Buy
+138,477
New +$2.9M ﹤0.01% 1400
2024
Q4 		– Sell
-114,104
Closed -$3.25M – 2777
2024
Q3 		$3.25M Buy
+114,104
New +$3.37M ﹤0.01% 1170
2024
Q2 		– Sell
-53,533
Closed -$1.73M – 2725
2024
Q1 		$1.73M Buy
+53,533
New +$1.95M ﹤0.01% 1429
2023
Q4 		– Sell
-5,900
Closed -$227K – 2370
2023
Q3 		$227K Buy
+5,900
New +$133K ﹤0.01% 1954
2023
Q1 		– Sell
-38,953
Closed -$691K – 2869
2022
Q4 		$691K Buy
+38,953
New +$490K ﹤0.01% 2242
2022
Q1 		– Sell
-8,316
Closed -$71K – 3644
2021
Q4 		$71K Sell
8,316
-64,506
-89% -$533K ﹤0.01% 3471
2021
Q3 		$633K Buy
72,822
+55,655
+324% +$502K ﹤0.01% 2280
2021
Q2 		$181K Sell
17,167
-4,027
-19% -$56.2K ﹤0.01% 2465
2021
Q1 		$340K Buy
21,194
+15,739
+289% +$415K ﹤0.01% 2085
2020
Q4 		$252K Buy
+5,455
New +$252K ﹤0.01% 1696
2020
Q3 		– Sell
-63,511
Closed -$1.55M – 1742
2020
Q2 		$1.55M Buy
63,511
+52,475
+475% +$1.12M 0.01% 877
2020
Q1 		$172K Buy
+11,036
New +$166K ﹤0.01% 1207

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace's IMVT Position: Q2 2026 in Review

Marshall Wace reduced its Immunovant (IMVT) stake by 14% in Q2 2026, selling an estimated $695K and leaving 142,488 shares worth $5.49M. The position accounts for ﹤0.01% of the portfolio, ranked #1321.

Marshall Wace first reported a position in IMVT in Q1 2020 and has held it in 15 quarters since. The position peaked at $6.77M in Q3 2025. 227 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Marshall Wace held 142,488 shares of Immunovant worth $5.49M as of Q2 2026.
  • Marshall Wace sold 22,812 Immunovant shares in Q2 2026, an estimated $695K.
  • Immunovant made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #1321 holding.
  • Marshall Wace first reported a position in Immunovant in Q1 2020 and has held it in 15 quarters since.
  • Marshall Wace's Immunovant position peaked at $6.77M in Q3 2025.
  • 227 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.